Epsilon Healthcare (ASX:EPN) Total Stockholders Equity: A$1.91 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Epsilon Healthcare Total Stockholders Equity?

Epsilon Healthcare ASX:EPN -7.69% Total Stockholders Equity is A$1.91 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Epsilon Healthcare's Total Stockholders Equity for the quarter that ended in Dec. 2025 was A$1.91 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Epsilon Healthcare's Book Value per Share for the quarter that ended in Dec. 2025 was A$0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Epsilon Healthcare's Debt-to-Equity for the quarter that ended in Dec. 2025 was 5.41.


Epsilon Healthcare  (ASX:EPN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Epsilon Healthcare's Book Value per Share for the quarter that ended in Dec. 2025 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Epsilon Healthcare's Debt-to-Equity for the quarter that ended in Dec. 2025 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epsilon Healthcare Total Stockholders Equity Related Terms


Epsilon Healthcare Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Epsilon Healthcare's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epsilon Healthcare Total Stockholders Equity Chart

Epsilon Healthcare Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only 30.86 21.86 7.54 -2.08 1.91

Epsilon Healthcare Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.54 6.10 -2.08 -3.62 1.91
What does a Total Stockholders Equity of A$1.91 Mil mean?
Epsilon Healthcare (ASX:EPN) has a Total Stockholders Equity of A$1.91 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Epsilon Healthcare and its competitors.
Is Epsilon Healthcare's Total Stockholders Equity too high?
Epsilon Healthcare's current Total Stockholders Equity is A$1.91 Mil.
How does Epsilon Healthcare's Total Stockholders Equity compare to ZTS?
Epsilon Healthcare's Total Stockholders Equity of A$1.91 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Epsilon Healthcare and its competitors. Epsilon Healthcare's current Total Stockholders Equity is A$1.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epsilon Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Epsilon Healthcare (ASX:EPN) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.02 — trading 20% below its estimated fair value. The current Total Stockholders Equity is A$1.91 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Epsilon Healthcare (ASX:EPN), the current Total Stockholders Equity is A$1.91 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epsilon Healthcare Business Description

Other Exchanges HDRPF:USA
Address 5 Goodyear Street, Southport, QLD, AUS, 4215
Epsilon Healthcare Ltd is an Australian based, globally active healthcare organisation. It operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacturing operation & pharmacy services. The company offers end-to-end solutions across the healthcare spectrum: from product development and manufacturing to patient care. The company's three (3) main operating segments are: a. Contract Development and Manufacturing activities, b. Telehealth medical practice services; and c. Pharmacy services. The majority of revenue is derived from the Contract Development and Manufacturing activities segment.